Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 7, 2007, Pages 1444-1448

  Okamura, Naoe ^a   Hashimoto, Kenji ^b   Iyo, Masaomi ^c   Shimizu, Eiji ^c   Dempfle, Astrid ^d   Friedel, Susann ^e   Reinscheid, Rainer K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

G protein coupled receptor; Neuropeptide; Panic disorder; Single nucleotide polymorphism

Indexed keywords

NEUROPEPTIDE S RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; AROUSAL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG SENSITIVITY; FEMALE; GENETIC CODE; GENOTYPE; HUMAN; JAPANESE; MALE; NEUROPROTECTION; PANIC; RECEPTOR GENE; SCHIZOPHRENIA; SEX DIFFERENCE; TRANQUILIZING ACTIVITY;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FAMILY; FEMALE; GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; JAPAN; MALE; MIDDLE AGED; PANIC DISORDER; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 34548135236     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.06.026     Document Type: Article

References (25)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (1994), American Psychiatric Publishing, Washington, DC
2. Bernier V., Stocco R., Bogusky M.J., Joyce J.G., Parachoniak C., Grenier K., et al. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem 281 (2006) 24704-24712
3. Bourin M., Malinge M., and Guitton B. Provocative agents in panic disorder. Therapie 50 (1995) 301-306
4. Chambless D.L., and Mason J. Sex, sex-role stereotyping and agoraphobia. Behav Res Ther 24 (1986) 231-235
5. Cox B.J., Swinson R.P., Shulman I.D., Kuch K., and Reichman J.T. Gender effects and alcohol use in panic disorder with agoraphobia. Behav Res Ther 31 (1993) 413-416
6. Crowe R.R., Noyes R., Pauls D.L., and Slymen D. A family study of panic disorder. Arch Gen Psychiatry 40 (1983) 1065-1069
7. Crowe R.R., Goedken R., Samuelson S., Wilson R., Nelson J., and Noyes Jr. R. Genomewide survey of panic disorder. Am J Med Genet 105 (2001) 105-109
8. Feng Y., Hong X., Wang L., Jiang S., Chen C., Wang B., et al. G protein-coupled receptor 154 gene polymorphism is associated with airway hyperresponsiveness to methacholine in a Chinese population. J Allergy Clin Immunol 117 (2006) 612-617
9. Hafner R.J. Agoraphobia in men. Aust N Z J Psychiatry 15 (1981) 243-249
10. Hebebrand J., Dempfle A., Saar K., Thiele H., Herpertz-Dahlmann B., Linder M., et al. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 11 (2006) 196-205
11. Knapp M., and Becker T. Family-based association analysis with tightly linked markers. Hum Hered 56 (2003) 2-9
12. Knowles J.A., Fyer A.J., Vieland V.J., Weissman M.M., Hodge S.E., Heiman G.A., et al. Results of a genome-wide genetic screen for panic disorder. Am J Med Genet 81 (1998) 139-147
13. Lage R., Dieguez C., and Lopez M. Caffeine treatment regulates neuropeptide S system expression in the rat brain. Neurosci Lett 410 (2006) 47-51
14. Laitinen T., Polvi A., Rydman P., Vendelin J., Pulkkinen V., Salmikangas P., et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304 (2004) 300-304
15. Logue M.W., Vieland V.J., Goedken R.J., and Crowe R.R. Bayesian analysis of a previously published genome screen for panic disorder reveals new and compelling evidence for linkage to chromosome 7. Am J Med Genet B Neuropsychiatr Genet 121 (2003) 95-99
16. Noyes Jr. R., Clancy J., Hoenk P.R., and Slymen D.J. The prognosis of anxiety neurosis. Arch Gen Psychiatry 37 (1980) 173-178
17. Noyes Jr. R., Crowe R.R., Harris E.L., Hamra B.J., McChesney C.M., and Chaudhry D.R. Relationship between panic disorder and agoraphobia. A family study. Arch Gen Psychiatry 43 (1986) 227-232
18. O'Connell J.R., and Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63 (1998) 259-266
19. Oei T., Wanstall K., and Evans L. Sex differences in panic disorder with agoraphobia. J Anxiety Disord 4 (1990) 317-324
20. Reinscheid R.K., Xu Y.L., Okamura N., Zeng J., Chung S., Pai R., et al. Pharmacological characterization of human and murine neuropeptide S receptor variants. J Pharmacol Exp Ther 315 (2005) 1338-1345
21. Weissman M.M., Wickramaratne P., Adams P.B., Lish J.D., Horwath E., Charney D., et al. The relationship between panic disorder and major depression. A new family study. Arch Gen Psychiatry 50 (1993) 767-780
22. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54 (1997) 305-309
23. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497
24. Yonkers K.A., Zlotnick C., Allsworth J., Warshaw M., Shea T., and Keller M.B. Is the course of panic disorder the same in women and men?. Am J Psychiatry 155 (1998) 596-602
25. Yonkers K.A., Bruce S.E., Dyck I.R., and Keller M.B. Chronicity, relapse, and illness-course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety 17 (2003) 173-179